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IL-10 Production in Macrophages Is Regulated by a TLR-
Driven CREB-Mediated Mechanism That Is Linked to Genes
Involved in Cell Metabolism
David E. Sanin,1 Catriona T. Prendergast,2 and Adrian P. Mountford
IL-10 is produced by macrophages in diverse immune settings and is critical in limiting immune-mediated pathology. In helminth
infections, macrophages are an important source of IL-10; however, the molecular mechanism underpinning production of IL-10 by
these cells is poorly characterized. In this study, bone marrow–derived macrophages exposed to excretory/secretory products
released by Schistosoma mansoni cercariae rapidly produce IL-10 as a result of MyD88-mediated activation of MEK/ERK/RSK
and p38. The phosphorylation of these kinases was triggered by TLR2 and TLR4 and converged on activation of the transcription
factor CREB. Following phosphorylation, CREB is recruited to a novel regulatory element in the Il10 promoter and is also
responsible for regulating a network of genes involved in metabolic processes, such as glycolysis, the tricarboxylic acid cycle, and
oxidative phosphorylation. Moreover, skin-resident tissue macrophages, which encounter S. mansoni excretory/secretory products
during infection, are the first monocytes to produce IL-10 in vivo early postinfection with S. mansoni cercariae. The early and
rapid release of IL-10 by these cells has the potential to condition the dermal microenvironment encountered by immune cells
recruited to this infection site, and we propose a mechanism by which CREB regulates the production of IL-10 by macrophages in
the skin, but also has a major effect on their metabolic state. The Journal of Immunology, 2015, 195: 1218–1232.
I
nterleukin-10 is known to be critical in maintaining the
balance between a strong prophylactic immune response and
limiting immune-mediated pathology during many diseases
caused by parasitic protozoa and helminths, as reviewed recently
(1). The importance of IL-10 has been demonstrated particularly
during human Schistosoma sp. infection (2–4) and in the murine
chronic model of this disease (5–8). However, until only recently,
the role of this cytokine had not been investigated during the early
stages of schistosome infection, as the host’s skin is exposed to
infective cercariae. The production of IL-10 increases substan-
tially in the skin site of infection, especially after repeated expo-
sure to cercariae (9), and is responsible for the induction of CD4
T cell hyporesponsiveness in the skin draining lymph nodes (10)
and prevention of excessive tissue damage/inflammation in the
skin (11). Although CD4+ T cells (often CD25+) are the primary
cellular source of IL-10 during the chronic phase of Schistosoma
mansoni infection (1, 12), shortly after exposure of the skin to
S. mansoni cercariae, both tissue macrophages and CD4+ T cells
were reported to produce IL-10 (11). However, the molecular
mechanism underpinning production of IL-10 by macrophages has
not been fully characterized.
Macrophages and dendritic cells (DCs) produce IL-10 in re-
sponse to TLR and C-type lectin receptor ligands (13–15). The
mechanism that controls IL-10 production in these cells in re-
sponse to defined stimuli (e.g., LPS and zymosan) is thought to
involve MAPKs, such as ERK, p38, mitogen and stress-activated
protein kinases (14, 16), and transcription factors, like CREB, NF-
kB p50 homodimers, and C/EBPb (13, 16–19). In addition to
stimulation of TLR and C-type lectin receptor on the cell surface,
macrophages are phagocytic and constantly sample their envi-
ronment by actively internalizing foreign macromolecules by
endocytosis. Endocytosis is tightly regulated as it is energy costly
(20), and it modulates downstream signaling pathways (21, 22).
However, the role of Ag uptake is only partly understood in the
context of TLR signaling, and the impact of endocytosis on the
production of IL-10 has not been studied.
During S. mansoni percutaneous infection, the earliest sources
of Ag to interact with innate immune cells in the skin are cer-
carial excretory/secretory (E/S) products (0–3 h released products
[0–3hRP]), which are released by cercariae as they penetrate the
host (23, 24). These E/S products contain .70 different proteins
(25, 26), some of which are glycosylated (27), but only a few have
defined roles in assisting extracellular matrix remodeling (24, 28,
Department of Biology, Centre for Immunology and Infection, University of York,
York YO10 5DD, United Kingdom
1Current address: Department of Pathology and Immunology, Washington University
in St. Louis, St. Louis, MO.
2Current address: Institute of Infection, Immunity and Inflammation, University of
Glasgow, Glasgow, U.K.
Received for publication January 22, 2015. Accepted for publication May 27, 2015.
This project was supported by Wellcome Trust Project Grant 092745/Z/10/Z (to
A.P.M.). D.E.S. was supported by the Fundacio´n para el Futuro de Colombia
(COLFUTURO) and the Departamento Administrativo de Ciencia, Tecnologı´a
e Innovacio´n de la Repu´blica de Colombia (COLCIENCIAS). C.T.P. was supported
by the Wellcome Trust.
D.E.S. and C.T.P. performed the experiments and analyzed the results; and D.E.S.,
C.T.P., and A.P.M. wrote the paper.
The sequences presented in this article have been submitted to the National Center
for Biotechnology Information’s Gene Expression Omnibus (http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE64844) under accession number GSE64844.
Address correspondence and reprint requests to Dr. Adrian P. Mountford, Department
of Biology, Centre for Immunology and Infection, University of York, York YO10
5DD, U.K. E-mail address: adrian.mountford@york.ac.uk
The online version of this article contains supplemental material.
Abbreviations used in this article: BMM, bone marrow–derived macrophage; ChIP,
chromatin immunoprecipitation; DC, dendritic cell; DEC, dermal exudate cell; EEA,
early endosome Ag; Egr1, early growth response protein 1; E/S, excretory/secretory;
Fos, FBJ osteosarcoma oncogene; Fw, forward; GO, gene ontology; 0–3hRP, 0–3 h
released products; 0–3hRPAF633, 0–3hRP conjugated to Alexa Fluor 633; MFI, me-
dian fluorescence intensity; MHC-II, MHC class II; Rv, reverse; TPL2, tumor pro-
gression locus 2; WT, wild-type.
This is an open-access article distributed under the terms of the CC-BY 3.0 Unported
license.















29), or modulating innate immune cells (30–32). Indeed, macro-
phages, as well as DCs, are among the earliest cells in the skin to
take up cercarial E/S products (23). These E/S products induce the
production of various cytokines by macrophages in vitro (32–34),
for which MyD88 and TLR4 are important (34), but their ability to
specifically induce IL-10 is not known.
In this study, the molecular mechanism underpinning production
of IL-10 by bone marrow–derived macrophages (BMMs) exposed
to E/S products released by S. mansoni cercariae was investigated.
We demonstrate that rapid production of IL-10 results from
MyD88-mediated activation of two branches of the MAPK sig-
naling pathway, MEK/ERK/RSK and p38, following ligation of
TLR2 and TLR4. Moreover, these kinases converge upon activa-
tion of the transcription factor CREB, which is critical for pro-
duction of IL-10. We show that CREB is recruited to a novel
regulatory element in the Il10 promoter as a consequence of
macrophage stimulation with 0–3hRP and that it regulates a net-
work of genes involved in metabolic processes. Finally, we in-
vestigated the production of IL-10 in vivo by monocytes in the
skin early postinfection with S. mansoni cercariae and suggest
a possible mechanism by which macrophages in the skin produce




Wild-type C57BL/6 (WT), IL-102/2 (IL-10–deficient) (35), TLR22/2
(TLR2-deficient) (36), as well as transgenic IL-10 reporter knockin (tiger)
(IL-10+/GFP) (37) mice were bred and housed at the University of York
(York, U.K.). Bone marrow from TLR42/2 or MyD882/2 strains (38, 39)
was obtained from mice housed at the University of Edinburgh (Edinburgh,
U.K.), whereas bone marrow cells deficient in tumor progression locus
2 (TPL2; Tpl22/2) (40) were obtained from animals housed at the National
Institute for Medical Research (London, U.K.). All transgenic strains were
on a B6 genetic background. Female mice aged between 6 and 10 wk were
used for all experiments carried out in accordance with the U.K. Animal’s
Scientific Procedures Act 1986 and with approval of the University of York
Ethics Committee.
Parasites and parasite-derived material
Infective S. mansoni cercariae (Puerto Rican strain) were obtained from
Biomphalaria glabrata snails exposed to incandescent light for 2 h. Cer-
cariae were collected, washed with chilled filter-sterilized water, and used
to collect cercarial E/S products as described previously (32, 34, 41).
Mechanically transformed cercariae were cultured for 3 h and the resulting
culture supernatant containing cercarial E/S products concentrated using
filter spin columns with an m.w. cutoff of 3 kDa (GE Life Sciences,
Pittsburgh, PA). This concentrated supernatant was termed 0–3hRP (34,
41) and its protein content determined by BCA protein assay (Thermo
Scientific, Waltham, MA). In selected experiments, 0–3hRP was conju-
gated to Alexa Fluor 633 (Life Technologies, Paisley, U.K.) (0–3hRPAF633)
by incubating together for 3 h (1 mg of dye per 100 mg 0–3hRP) and then
removing excess dye with a filter spin column.
In vitro culture and stimulation of BMMs
Macrophages were derived from the bone marrow using a well-established
experimental system;methodological details defined as being critical during
cell culture (42) are given below. Aliquots of bone marrow cells (5 3 106)
were cultured for 7 d (37˚C 5% CO2) in DMEM (Life Technologies)
containing 10% heat-inactivated FCS (Biosera, Uckfield, U.K.), 2 mM
L-glutamine solution, 50 U/ml penicillin, 50 mg/ml streptomycin (all Life
Technologies), and 50 mM 2-ME (Sigma-Aldrich, Gillingham, U.K.). Cell
cultures were supplemented with CSF-1 obtained from culture super-
natants of L929 murine fibroblast cell line. After 7 d, adherent cells were
harvested and subsequently used as BMMs.
BMMs were cultured in complete DMEM (1 3 105 cells/ml) and stim-
ulated for 10–1000 min with 50 mg/ml 0–3hRP [low endotoxin 0.0015 6
0.0003 mg/ml (34)], 0–3hRPAF633, or medium control (Media), all
supplemented with 2 mg/ml polymixin B (Sigma-Aldrich) (34, 41).
Additionally, BMMs were stimulated with 1 ng/ml LPS (Sigma-Aldrich),
25 mg/ml polyinosinic-polycytidylic acid (Sigma-Aldrich), or 5 mg/ml
Pam3CSK4 (Invivogen, San Diego, CA). In selected experiments,
BMMs were pretreated for 2 h with MEK inhibitor U0126 (3–30 mmol),
p38 inhibitor SB203580 (0.3–3 mmol), PI3K family inhibitor LY294002
(25 mmol) (all from Cell Signaling Technology, Leiden, the Netherlands),
or p110-d inhibitor IC87114 (5 mg/ml) kindly donated by Dr. Klaus
Okkenhaug (University of Cambridge, Cambridge, U.K.). Glucose in
culture supernatants was measured with a Glucose (GO) assay kit (Sigma-
Aldrich), whereas lactate was estimated using a Lactate colorimetric assay
kit (BioVision, Mountain View CA). Hexokinase activity (in units per
milliliter) of stimulated cells was measured using a Hexokinase colori-
metric assay (BioVision).
Infection protocol and recovery of dermal exudate cells
Mice were percutaneously exposed via each pinna to a single dose of 150
S. mansoni cercariae and pinnae harvested 1, 2, or 4 d postinfection.
Pinnae from naive and infected mice were removed and split along the
central cartilage into two halves to obtain the population of dermal exudate
cells (DEC), as described previously (9, 43).
Flow cytometry
Cells were blocked with 1 mg anti-CD16/32 mAb (eBioscience, Hatfield,
U.K.) in goat serum (Sigma-Aldrich) and then labeled with LIVE/DEAD
Fixable Aqua Dead Cell Stain (Life Technologies), plus the following
mAbs conjugated to various fluorescent labels: anti–MHC class II (MHC-
II; IA-IE) (clone M5/114), anti-CD11b (clone M1/70), and anti-F4/80
(clone BM8) (all from eBioscience). For intracellular staining of phos-
phorylated proteins, cells were washed, fixed with 2% paraformaldehyde,
and incubated in 13 permeabilization buffer (eBioscience) with polyclonal
Abs against ERK1/2, p-ERK1/2, p38, p-p38, or mAbs against RSK (clone
32D7), p-RSK (clone D5D8), CREB (clone 48H2), p-CREB (clone 87G3),
p-p65 (93H1), and p-p65 (18E6) (all from Cell Signaling Technology).
Finally, BMMs were incubated in 13 permeabilization buffer with Alexa
Fluor 488–conjugated goat anti-rabbit Ab (Life Technologies). All flow
cytometry was acquired using the Cyan ADP analyzer (DakoCytomation,
Stockport, U.K.), or BD LSR Fortessa analyzer (BD Biosciences, Ox-
ford, U.K.) and data analyzed using FlowJo software v7.6.5 (Tree Star,
Ashland, OR).
Detection of intracellular IL-10 in DEC
WT and IL-10+/GFP mice were infected and pinnae harvested as described
above. Split pinnae were incubated with complete RPMI 1640 for 12 h
prior to the addition of 13 Brefeldin A (eBioscience) for a further 8 h.
DEC were then prepared for flow cytometric analysis as described above.
Cytokine analysis by ELISA
Culture supernatants were collected from BMM cell cultures, and IL-10,
IL-12p40, and IL-12p70 were quantified by DuoSet ELISA (R&D Sys-
tems, Abingdon, U.K.).
Confocal microscopy and immunofluorescence
BMMs were allowed to adhere to glass cover slips for 2 h in 24-well plates
(1 3 106 cells/well) prior to stimulation with 0–3hRPAF633 (50 mg/ml) for
60 min. Cells were washed, fixed on to cover slips for 20 min with 4%
paraformaldehyde in PBS at room temperature, and placed in 0.05% sa-
ponin 0.2% BSA (staining buffer) for 30 min at room temperature before
being incubated for 1 h with polyclonal rabbit Ab against early endosome
Ag (EEA)-1 (Abcam; 1:200). Cover slips were washed three times and
then probed for 1 h with goat anti-rabbit Alexa Fluor 488 (Life Technol-
ogies) (1:1000), washed as before, and counterstained with DAPI (2 mg/ml)
(Sigma-Aldrich). Cover slips were mounted onto glass slides using Prolong
Gold (Life Technologies). Images were acquired using a Zeiss 710 inverse
confocal microscope (Carl Zeiss, Cambridge, U.K.) and all analyzed using
identical acquisition settings in Zeiss ZEN software (Carl Zeiss). Image
handling (including contrast adjustment) was conducted using ImageJ
(National Institutes of Health).
RNA extraction and gene expression analysis by PCR
RNA from stimulated BMMs (2 3 106) was obtained using the High Pure
RNA isolation kit (Roche, Burgess Hill, U.K.) and quantified using a
Nanodrop (Thermo Scientific). Purified RNA was reverse transcribed into
cDNA using SuperScript (Life Technologies) and the resulting cDNA
analyzed for gene expression via quantitative real-time PCR using Fast
SYBR Green Master Mix (Life Technologies) and primers (0.8 mmol) for
Il10 (forward [Fw]: 59-GGTCTTGGGAAGAGAAACCAG-39 and reverse














[Rv]: 59-GCCACAGTTTTCAGGGATGA-39) and Il12b (Fw: 59-ATCAA-
GAGCAGTAGCAGTTC-39 and Rv: 59-TACTTCTCATAGTCCCTTTG-39).
For early growth response protein 1 (Egr1), FBJ osteosarcoma oncogene
(Fos), and NF-kB 2 (Nfkb2), primers were designed and validated directly
by the manufacturer (Qiagen, Venlo, the Netherlands). Changes in gene
expression after quantitative real-time PCR using a StepOnePlus PCR sys-
tem (Life Technologies) were calculated using the d-d threshold cycle
method (44) with Gapdh (Fw: 59-CCATGTTTGTGATGGGTGTG-39 and
Rv: 59-CCTTCCACAATGCCAAAGTT-39) as a housekeeping gene.
Chromatin immunoprecipitation PCR and sequencing
Sonicated covalently linked chromatin (∼200 bp), obtained using a chro-
matin immunoprecipitation (ChIP) assay kit (Merck Millipore, Watford, U.K.)
and a Bioruptor plus (Diagenode, Seraign, Belgium), from 53 106 BMMs
stimulated for 30 min with 50 mg/ml 0–3hRP was immunoprecipitated with
the following Abs: anti–p-CREB (clone 87G3), anti-CREB (clone 48H2) (both
from Cell Signaling Technology), anti-RNA polymerase II (Merck Millipore),
or anti-CD36 (Cayman Chemical, Ann Arbor, MI). DNAwas recovered by
reversing chromatin crosslinking and extracted using phenol-chloroform
extraction. Extracted DNA was dissolved in 50 ml PCR-grade water and
used for conventional PCR using four primer pairs expanding the +1 kb
of the Il10 promoter (first, Fw: 59-AGAGGAGAGTTCTGGTGCCT-39 and
Rv: 59-GGTGACTTCCGAGTCAGCAA-39; second, Fw: 59-AGAGGCCCT-
CATCTGTGGAT-39 and Rv: 59-GCAGAAGTTCATTCCGACCA-39; third,
Fw: 59-TGTGGCTTTGGTAGTGCAAG-39 and Rv: 59-TGCTGCCTGCT-
CTTACTGAC-39; and fourth, Fw: 59-CTAGGAGCATGTGGCTCTGG-39 and
Rv: 59-GTCTACCCGACAGCACAGAG-39) or sent for sequencing. DNA li-
braries, sequencing, peak calling, and enrichment analysis were carried out by
the Centre for Genomic Research at the University of Liverpool (Liverpool,
U.K.). Detailed experimental design, protocol, data processing pipeline, and
data have been deposited in National Center for Biotechnology Information’s
Gene Expression Omnibus (45) and are accessible through accession number
GSE64844 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE64844).
Peaks with a ,5% predicted false discovery rate and .65 peak scores
[210*log10(p value)] were annotated automatically with level of en-
richment and used for subsequent analysis.
Bioinformatics
Enriched peaks from ChIP sequencing data were visualized using the In-
tegrative Genomics Viewer (46). Cytoscape (47, 48) and the app BinGO
(49) were used to calculate gene ontology (GO) term enrichment, with
a corrected p value cutoff of 0.05, and to generate GO term networks.
Statistics
ANOVA and multiple comparisons tests (Bonferroni, Tukey, Sidak, and
Dunnett) were performed to establish statistically significant differences
between the groups (*p , 0.05, **p , 0.01, ***p , 0.001, ****p ,
0.0001) using the software package GraphPad Prism (GraphPad Software,
La Jolla, CA). Error bars represent SEM, based on biological replicates
(i.e., pinnae from infected mice or separate bone marrow cell cultures from
different animals).
Results
BMMs rapidly internalize S. mansoni cercarial E/S products
and produce IL-10 in a TLR-dependent manner
Discrete vesicles containing 0–3hRPAF633 were observed in BMMs
at 60 min poststimulation, in both EEA-1+ (Fig. 1A, white arrows)
and EEA-12 vesicles (Fig. 1A, yellow arrows). Upon quantification,
uptake of 0–3hRPAF633 between 10 and 300 min was revealed to be
rapid but sustained, with median fluorescence intensity (MFI) val-
ues significantly greater in 0–3hRPAF633 exposed BMMs compared
with corresponding media controls as early as 10 min poststimu-
lation, rising thereafter out to 300 min (Fig. 1B, 1C; p , 0.05–
0.0001). Similarly, increased levels of Il10 transcript were detected
rapidly after stimulation with 0–3hRP with significantly greater
expression at 30 and 100 min after stimulation with 0–3hRP
(Fig. 1D; p , 0.0001). In contrast, increased quantities of Il12b
were only apparent by 100 min (Fig. 1E; p , 0.0001). The se-
cretion of IL-10 protein by stimulated BMMs was more rapid
(i.e., by 100 min, Fig. 1F) than the secretion of IL-12p40, which
was only significantly elevated after 300 min (Fig. 1G).
IL-10 production in BMMs exposed to 0–3hRP was depen-
dent on MyD88 signaling, but also on the presence of TLR2
and TLR4, as the production of this cytokine was reproducibly
and greatly impaired in cells deficient for these molecules
(Fig. 1H; p , 0.001). IL-12p40 production was similarly af-
fected by the absence of these proteins (Fig. 1I; p , 0.001),
although the absence of TLR2 appeared to have a more mar-
ginal role.
BMMs stimulated with cercarial E/S products employ TLRs to
activate ERK1/2, p38, and CREB
As TLR-driven IL-10 production in BMMs occurred rapidly
(30 min) after stimulation with 0–3hRP, early phosphoryla-
tion events in these cells were investigated. A kinase profiler
array revealed that several proteins became phosphorylated after
stimulation including ERK1/2, p38, and CREB (Supplemental
Fig. 1, white arrows). Although limited activation of these
kinases was seen after 5 min (Supplemental Fig. 1, top panel),
all three were abundantly phosphorylated after 30 min
(Supplemental Fig. 1, middle panel) and were still detectable
after 60 min (Supplemental Fig. 1, bottom panel). Significantly
greater levels of IL-10 were detected in culture supernatants of
BMMs treated with 0–3hRP compared with TLR agonists LPS,
polyinosinic-polycytidylic acid, and Pam3CSK4 (Supplemental
Fig. 2A, p , 0.05–0.001), whereas significantly lower levels of
IL-12p40 were obtained after 0–3hRP stimulation (Supplemental
Fig. 2A, p , 0.001–0.0001). Moreover, both ERK2 and CREB
phosphorylation was significantly elevated in 0–3hRP stimu-
lated BMMs compared with LPS (Supplemental Fig. 2C–E;
p , 0.0001), whereas phosphorylation of p38 was equivalent
(Supplemental Fig. 2C, 2F). Phosphorylation dynamics of all
three kinases were closely examined using flow cytometry (Fig.
2A–C), as this technology has been widely used to study phos-
phorylation of proteins at a cellular level permitting truly quan-
titative and statistical analysis, while avoiding artifacts introduced
by enzymatic amplification and dead cells (50, 51). Our data
expressed as mean MFI 6 SEM using four biological repli-
cates representative of three independent experiments revealed
that all three kinases shared similar activation profiles, with maxi-
mal phosphorylation detected 30 min after stimulation with 0–3hRP
(Fig. 2D–F; p , 0.0001), and this was verified for ERK1/2 by
Western blot (Supplemental Fig. 2G). In comparison, no significant
changes were detected in the levels of total protein (Fig. 2G–I).
Phosphorylation of ERK1/2, p38, and CREB was entirely depen-
dent on the availability of MyD88 and was partly dependent on the
presence TLR2 and TLR4 (Fig. 2J–L; p , 0.01–0.0001). Conse-
quently, 0–3hRP–driven activation of these three MAPK was
dependent on TLR signaling, as previously shown for IL-10
production.
Both p65 and p105 components of the NF-kB system were
likewise phosphorylated after exposure to 0–3hRP (Supplemental
Fig. 3A, 3B), although the activation profile did not resemble
that of ERK1/2, p38, and CREB (Supplemental Fig. 3D, 3E).
In contrast, although RSK became phosphorylated in 0–3hRP–
stimulated BMMs (Supplemental Fig. 3C), it shared the same
activation profile as ERK1/2, p38, and CREB (Supplemental Fig.
3F) and did not exhibit significant changes in the total levels of
RSK protein (Supplemental Fig. 3G).
Chemical inhibition of p38 prior to stimulation of BMMs
with 0–3hRP resulted in reduced phosphorylation of CREB
(Fig. 3A, 3C; p , 0.05), similar to the effects after the chemical
inhibition of MEK1/2 (Fig. 3B, 3C; p , 0.05), indicating that
both p38 and MEK/ERK are upstream of CREB. In contrast,
inhibition of p38 had no effect on the phosphorylation of














ERK1/2 (Fig. 3D), whereas MEK1/2 inhibitor completely ab-
lated phosphorylation of ERK1/2 (Fig. 3D; p , 0.001). Inhi-
bition of p38 using SB203580 is known to have no effects over
the levels of phosphorylated p38 (52), in line with our own
finding (Fig. 3E). Inhibition of MEK1/2 also had no effect
on p38 phosphorylation (Fig. 3E). Thus, off-target effects of
p38 and MEK1/2 inhibitors did not account for the observed
reductions in CREB phosphorylation, and consequently, it was
concluded that CREB activation was a result of p38 and MEK/
ERK activation. Inhibition of p38 had no effect on the phos-
phorylation of RSK in 0–3hRP–stimulated BMMs compared
with resting cells, whereas inhibition of MEK/ERK resulted in
a significant reduction (Supplemental Fig. 3H; p , 0.0001),
indicating that MEK/ERK are upstream of RSK.
FIGURE 1. BMMs internalize cercarial E/S products and produce IL-10 in a TLR-dependent manner. (A) Representative confocal image (12 3 20 mm)
of a BMM exposed to 50 mg/ml 0–3hRPAF633 (red) for 60 min, labeled with anti–EEA-1 Abs (cyan), and counterstained with DAPI (blue). Arrowheads
indicate the location of 0–3hRPAF633 within EE-A+ (white) or EEA-12 (yellow) endosomes. Cell membrane is shown in white. Representative overlaid flow
cytometry histograms (B) and mean MFI6 SEM (C) of BMMs exposed to 50 mg/ml 0–3hRPAF633 (closed circles) or media control (open circles). Symbols
are means of three technical replicates. Fold changes in transcript RNA (D and E) and protein levels of IL-10 and IL-12p40 (F and G) in cultures of WT
BMMs exposed to 50 mg/ml 0–3hRP (closed circles) or corresponding media controls (open circles). Symbols represent mean from four biological
replicates. (H and I) IL-10 and IL-12p40 produced by overnight cultures of WT, MyD882/2, TLR22/2, or TLR42/2 BMMs exposed to 50 mg/ml 0–3hRP
or media. Histogram bars are means for selected groups of WT and transgenic BMMs (four biological replicates). ANOVA and multiple comparisons tests
(Bonferroni, Dunnett, and Sidak) were performed to examine statistically significant differences (C–G) between 0–3hRP–treated BMMs and corresponding
media control at each time point or (H and I) between treated BMMs from different strains of mice. Dotted lines represent no fold changes in RNA levels
(D and E) or lower detection limit of ELISA tests (F–I). Results are representative of three independent experiments. *p , 0.05, **p , 0.01, ***p , 0.001,
****p , 0.0001. ns, p . 0.05.














FIGURE 2. Cercarial E/S products trigger MAPK activation in BMMs in a TLR-dependent manner. Phosphorylation of MAPKs shown as representative
overlaid flow cytometry histograms (A–C) and mean MFI 6 SEM (D–I) for BMMs exposed to 50 mg/ml 0–3hRP (closed circles) or media control (open
circles). Results are shown at 30 min (A–C and J–L) or 0–100 min (D–I). MFI values are shown for phosphorylation of ERK1/2, p38, and CREB (A–F and J–
L) and for total MAPKs (G–I). Symbols and bars are means of four biological replicates and representative of three independent experiments. ANOVA and
multiple comparisons tests (Sidak and Bonferroni) were performed to examine statistically significant differences between 0–3hRP–treated BMMs and
corresponding media control at each time point (D–I) or between the means of selected groups of WT and transgenic BMMs (J and K) (four biological
replicates). *p , 0.05, **p , 0.01, ***p , 0.001, ****p , 0.0001. ns, p . 0.05.














ERK1/2, p38, and CREB control IL-10 and limit IL-12 in
BMMs stimulated with cercarial E/S products
The link between MAPK phosphorylation and cytokine production
was demonstrated because chemical inhibition of p38 resulted in
a significant dose-dependent decrease in IL-10 production by
BMMs exposed to 0–3hRP (Fig. 4A; p , 0.0001), whereas there
was a significant increase in the levels of IL-12p40 and IL-12p70
(Fig. 4B, 4C; p , 0.0001). Inhibition of MEK1/2 also resulted in
a marked reduction in the levels of IL-10 (Fig. 4D; p , 0.0001),
accompanied by significant increases in the production of IL-
12p40 and IL-12p70 (Fig. 4E, 4F; p , 0.0001). Consequently,
IL-10 production in BMMs stimulated with 0–3hRP is controlled
by ERK1/2 and p38.
Increased production of IL-12 by 0–3hRP–stimulated BMMs
treated with inhibitors for p38 and MEK1/2 could be a result
of the corresponding reduction in IL-10 production; however,
IL-102/2 BMMs exposed to 0–3hRP and treated with p38 in-
hibitor (Fig. 4G), or MEK1/2 inhibitor (Fig. 4H), exhibited sig-
nificantly increased levels IL-12p40 compared with uninhibited
controls (p, 0.001–0.0001). Thus, IL-12 production is limited by
the activation of p38 and ERK1/2 independently of IL-10. In
addition, BMMs deficient for TPL2, which is required for TLR-
driven ERK1/2 phosphorylation (40, 53), failed to phosphorylate
ERK1/2 in response to 0–3hRP (Supplemental Fig. 3I), but
exhibited increased levels of IL-12p40 (Supplemental Fig. 3J; p ,
0.0001), concurrent with decreased production of IL-10 (Supplemental
Fig. 3K; p , 0.05), further confirming the role of ERK1/2 in limiting
IL-12 production.
IL-10 production linked to rapid MAPK activation could be
related to the quick internalization of 0–3hRP by BMMs. Indeed,
uptake of 0–3hRPAF633 was significantly impaired from 100 min
with PI3K inhibitors (Fig. 5A, 5B). Decreased phosphorylation of
ERK1/2, p38, and CREB in BMMs stimulated with 0–3hRP for
30 min was recorded following inhibition using a p110d-specific
inhibitor (IC87114) or with a PI3K family inhibitor (LY294002)
(Fig. 5C–E; p, 0.0001). Both PI3K inhibitors greatly reduced the
production of IL-10 by stimulated BMMs (Fig. 5F; p , 0.001–
0.0001), but had no effect upon the production of IL-12p40
(Fig. 5G).
CREB is recruited to the IL-10 promoter in BMMs exposed to
0–3hRP
As BMMs appear likely to use TLR2 and TLR4 to recognize
0–3hRP, resulting in MyD88-mediated activation of MEK/ERK
and p38, which subsequently converge in the phosphorylation
of the transcription factor CREB, it is possible that CREB is
recruited to the IL-10 promoter, where it participates in the ini-
tiation of Il10 mRNA synthesis.
Using four sets of primers mapping the IL-10 promoter region
(Fig. 6A) to analyze fragmented chromatin obtained from BMMs
stimulated with 0–3hRP precipitated with Abs against p-CREB
and total CREB, a potential binding site for CREB was found
within the fourth region (Fig. 6B), which was the most enriched
portion of the promoter detected (Fig. 6C). Moreover, chromatin
precipitated with anti–Pol II Abs also produced a strong signal
with the fourth set of primers because Il10 is transcriptionally
active after 30 min of 0–3hRP stimulation (Fig. 6D). Much fainter
signals were detected from negative controls using Abs against
nonnuclear CD36 and no Ab control for all the primer pairs, as
shown in this study for the fourth set (Fig. 6D). Consequently,
p-CREB is recruited to the IL-10 promoter in BMMs 30 min after
exposure to 0–3hRP, where it is likely to modulate the transcrip-
tion of IL-10.
FIGURE 3. CREB is downstream from p38 and ERK1/2. Representative overlaid flow cytometry histograms (A and B) and mean MFI + SEM (C–E) of
BMMs treated with p38 inhibitor (SB203580, 1 mmol) or MEK inhibitor (U0126, 10 mmol) for 2 h and then exposed for 30 min to 50 mg/ml 0–3hRP
(closed bars) or media control (open bars). Cells were labeled with Abs against p-CREB (C), p-ERK1/2 (D), or p-p38 (E). Bars represent means of three
biological replicates. ANOVA and Tukey multiple comparisons test were performed to examine statistically significant differences between the means of
selected groups. Results are representative of four independent experiments. *p , 0.05, **p , 0.01, ***p , 0.001. ns, p . 0.05.














CREB regulates a network of genes in BMMs exposed to
0–3hRP
CREB-precipitated chromatin fragments were sequenced, and
those that were significantly enriched peaks (peak score .65)
based on input with a false discovery rate ,5% were identified
[raw data available at the National Center for Biotechnology
Information’s Gene Expression Omnibus (45), accession number
GSE64844]. After peak calling, 654 genes proximal to identified
peaks were analyzed for significant GO term enrichment (p ,
0.05), which were then used to create a network of “Biological
process” GO terms (Fig. 7A). Three discrete GO term clusters
were defined—“metabolism,” “localization,” and “biological
regulation” (Fig. 7B–D)—and GO terms within selected nodes
were further annotated with relevant Kyoto Encyclopedia of
Genes and Genomes pathways. The “localization” cluster in-
cluded genes involved in RNA transport by forming part of the
nuclear pore complex (Nup133), protein processing (Sar1a), or
endocytosis (Vps18) (Fig. 7C). Moreover, the “biological regula-
tion” cluster included genes involved in histone modification
(i.e., Ube2b and Ring1), as well as transcription factors (i.e., Egr1,
Fos, and Nfkb2) (Fig. 7C). The expression of this last group of
genes was confirmed in BMMs exposed to 0–3hRP for 30 min,
which significantly increased the levels of these transcripts com-
pared with media controls (Fig. 7E; p , 0.0001). In the case of
Egr1 and Fos, expression of these genes was partly dependent
upon ERK1/2 phosphorylation as chemical inhibition of MEK1/2
significantly reduced the levels of both transcripts (Fig. 7E; p ,
0.001). Thus, activation of CREB in 0–3hRP–stimulated BMMs,
through MEK/ERK and potentially p38, regulates the expression
of a network of genes involved in regulation of transcription.
Notably, the “Metabolic process” GO term was the most
enriched and contained 48.02% of all annotated genes. The me-
tabolism cluster, which includes this term, encompassed genes
involved with the initiation of glycolysis (Adpgk), key steps in the
tricarboxylic acid cycle (Aco2) and during oxidative phosphory-
lation (Ndufa10), whereas this GO term cluster also included
FIGURE 4. MAPK activation induces IL-10 production, while limiting IL-12. BMMs from WT (A–F) and IL-102/2 (G and H) mice were treated with
p38 inhibitor (SB203580, 0.3–3 mmol) (A–C and G) or MEK inhibitor (U0126, 3–30 mmol) (D–F and H) for 2 h and then exposed overnight to 50 mg/ml 0–
3hRP (closed circles) or media control (open circles). Culture supernatants were tested for the presence of IL-10 (A and D), IL-12p40 (B, E, G, and H), and
IL-12p70 (C and F). Symbols and bars are means of four biological replicates. ANOVA and multiple comparisons tests (Dunnett and Sidak) were performed
to examine statistically significant differences (A–F) between 0–3hRP–treated BMMs and corresponding media control at each dose of the inhibitor or
between the means of WT and IL-102/2 BMMs (G and H) (four biological replicates). Dotted lines represent lower detection limit in ELISA tests. Results
are representative of three independent experiments. *p , 0.05, **p , 0.01, ***p , 0.001, ****p , 0.0001. ns, p . 0.05.














genes involved in MAPK signaling and notably some upstream
from ERK1/2 (i.e., Braf, Nras, and Map2k1) (Fig. 7B). Indeed,
BMMs exposed to 0–3hRP depleted significantly more glucose
from culture medium than resting macrophages (Fig. 8A; p ,
0.001), although 0–3hRP–stimulated cells produced signifi-
cantly less lactate (Fig. 8B; p , 0.0001). Although glucose is
used as fuel in both oxidative phosphorylation and anaerobic
glycolysis, lactate is only the product of the latter, supporting
our hypothesis that BMMs exposed to 0–3hRP rely on oxidative
phosphorylation. Treatment of 0–3hRP–stimulated BMMs with
MEK1/2 inhibitor revealed that glucose consumption (Fig. 8C),
but not lactate production (Fig. 8D), is regulated by 0–3hRP–
triggered ERK1/2 phosphorylation. Indeed, BMMs treated with
MEK1/2 inhibitor consumed significantly less glucose than
their uninhibited counterparts (Fig. 8C; p , 0.0001). In ac-
cordance with observed glucose uptake, hexokinase activity
was also greatly enhanced in macrophages exposed to 0–3hRP
(Fig. 8E; p , 0.01) and was reduced after MEK1/2 inhibition
(Fig. 8E; p , 0.05). Consequently, energy metabolism in
BMMs following 0–3hRP stimulation, which relies heavily on
oxidative phosphorylation, is modulated by TLR mediated ac-
tivation of ERK1/2.
FIGURE 5. Uptake of 0–3hRP and PI3K signaling is required for full MAPK activation and IL-10 production by BMMs. Representative overlaid flow
cytometry histograms (A) and mean MFI 6 SEM (B) of BMMs pretreated for 2 h with PI3K inhibitor (LY294002; 25 mmol; gray line/squares) or left
untreated (circles) and then exposed to 50 mg/ml 0–3hRPAF633 (closed circles) or media control (dashed line, open circles) for 0–300 min. Symbols
represent means of three biological replicates. (C–G) BMMs pretreated for 2 h with PI3K inhibitors LY294002 or IC87114 or left untreated and then
exposed to 0–3hRP for 30 min (closed bars) or media control (open bars). Cells were labeled with Abs against p-ERK1/2 (C), p-p38 (D), or p-CREB (E).
Bars represent mean MFI + SEM of three biological replicates. Supernatants from BMM cultures treated with PI3K inhibitors LY294002 and IC87114 (F
and G) and stimulated with 0–3hRP (closed bars) or media control (open bars) were tested for the presence of IL-10 and IL-12p40. Bars represent means of
three biological replicates. ANOVA and multiple comparisons tests (Sidak and Dunnett) were performed to examine statistically significant differences (B–
G) between BMMs exposed to 0–3hRP only versus cells exposed 0–3hRP + inhibitor. Dotted lines are the lower detection limit in ELISA tests. Results are
representative of four independent experiments. **p , 0.01, ***p , 0.001, ****p , 0.0001. ns, p . 0.05.














Resident skin macrophages in vivo rapidly produce IL-10
following infection with S. mansoni cercariae
We attempted to address the relevance of the in vitro observations,
reported above in the context of in vivo conditions following infection
of a mammalian host, using skin exposed to S. mansoni cercariae.
Awell-characterized percutaneous infection model (9) was employed
to obtain DEC from infected pinnae to study IL-10 production by
monocytes at early time points. Three discrete monocyte pop-
ulations (R1: F4/802MHC-IIhigh; R2: F4/80+MHC-IIhigh; and
R3: F4/80+MHC-IImid) were evident within DEC based on the
expression of F4/80 and MHC-II (Fig. 9A). F4/80+MHC-IIhigh
tissue macrophages (R2) were the most abundant MHC-II+
population in naive skin (Fig. 9B). However, by day 1 postinfection,
the proportion of all three populations was not significantly different
(Fig. 9B), although by days 2 and 4, F4/802MHC-IIhigh DC (R1)
and F4/80+MHC-IIhigh tissue macrophages (R2) were equally abun-
dant, and both were significantly more abundant than F4/80+MHC-IImid
macrophages (R3) (Fig. 9B; p , 0.0001).
IL-10–producing MHC-II+ cells based on GFP expression in-
creased steadily from day 1 to day 4 after S. mansoni infection
(Fig. 9C, 9D), with most MHC-II+IL-10+ DEC detected on the
fourth day after cercarial penetration (p , 0.05–0.0001). Based
upon expression of F4/80 and MHC-II (as in Fig. 9A), IL-10+ F4/
80+MHC-IIhigh tissue macrophages (R2) were more abundant than
any other IL-10+ MHC-II+ cells in naive DEC, as well as on days
1 and 2 after S. mansoni infection (Fig. 9E; p , 0.0001). By day
4, the proportion of IL-10+ F4/802MHC-IIhigh DC (R1) and IL-
10+ F4/80+MHC-IIhigh tissue macrophages (R2) was equivalent
and significantly higher than IL-10+ F4/80+MHC-IImid macro-
phages (R3) (Fig. 9E; p , 0.0001). Consequently, penetration of
S. mansoni cercariae, and their subsequent release of E/S products,
triggers IL-10 production in vivo by two types of monocytes in the
skin, with tissue macrophages rapidly producing IL-10 after ex-
posure to the parasite. Thus, we propose a hypothetical model
(Fig. 10) based on our in vitro studies, by which tissue macro-
phages produce IL-10 after S. mansoni infection.
Discussion
BMMs stimulated with 0–3hRP exhibit an activation state char-
acterized by the production of abundant anti-inflammatory IL-10,
which followed the activation of several MAPKs downstream of
both TLR2 and TLR4. The activation profile of these kinases
matched the transcription of Il10 and resulted from recruitment of
CREB to the promoter region of Il10. Intriguingly, phosphoryla-
tion of CREB in BMMs stimulated with 0–3hRP was linked
to altered metabolic processes, particularly glycolysis, the tricar-
boxylic acid cycle, and oxidative phosphorylation, suggesting that
macrophages require specific metabolic programs to respond to
0–3hRP. Finally, we observed that during the first days postinfection
of the skin by S. mansoni cercariae, skin tissue macrophages were
FIGURE 6. CREB is recruited to a specific regulatory element of the Il10 promoter. (A) Scan strategy used to determine binding site in the Il10 promoter
for CREB using sets of primers to amplify four DNA fragments between 100 and 300 bp (dotted boxes). Transcription and translation start sites are
indicated above diagram. Agarose gel of amplified DNA fragments from Il10 promoter using all designed primers (B) and enrichment of promoter regions
based on densitometry analysis of PCR results (C). Sonicated chromatin from BMMs exposed to 0–3hRP for 30 min was precipitated using Abs against
p-CREB (black bar), total CREB (checked bar), plus [in (D)] control Abs for RNA polymerase II (Pol II) and CD36, alongside no Ab control. Results are
representative of four independent experiments. AU, arbitrary units.














the initial and dominant myeloid source of IL-10, and we propose
that when exposed to cercarial E/S products during infection, they
are likely to employ the mechanism we unraveled in vitro to
produce IL-10.
Several helminth products are known to be associated with
stimulation of various TLRs (54–57), whereas Schistosoma Ags
have been reported to interact with specific TLRs present on
mononuclear phagocytes (32, 34, 58, 59). However, few of these
FIGURE 7. TLR-activated CREB regulates an extensive network of genes in BMMs stimulated with cercarial E/S products. GO term enrichment network
divided into three clusters from enriched peaks + peak scores [210*log10(p value)] from sequenced fragments of sonicated chromatin from BMMs exposed
0–3hRP precipitated using an Ab against CREB calculated against input control. (A) Significantly enriched GO terms (p , 0.05) colored based on significance
(according to intensity of color gradient). Node size is representative of the number of genes mapping to each term. Significantly enriched genes within
“localization” (B), “biological regulation” (C), and “metabolism” (D) clusters, presented according to their GO term and KEGG pathway. (E) Mean fold change +
SEM for selected RNA transcript levels obtained from BMMs pretreated with MEK inhibitor or left untreated and then exposed to 0–3hRP or media control.
Bars represent means of three technical replicates. Statistically significant differences between the means of selected groups were determined using ANOVA and
Tukey multiple comparisons test. Dotted lines represent no-fold change in the levels of mRNA. ***p , 0.001, ****p , 0.0001. ns, p . 0.05.














studies describe the signaling pathways triggered in host cells or
indeed link them to the production of specific cytokines (58–60).
In the current study, we show that in BMMs stimulated with
0–3hRP, both TLR2 and TLR4 are necessary for the production of
IL-10 in a MyD88-dependent manner. As S. mansoni cercarial E/S
products are a complex mixture of glycosylated proteins (25, 27),
it is possible that TLR2 and TLR4 each recognize different
components of 0–3hRP, thus explaining the differences in IL-12
production observed in the absence of TLR2 versus TLR4.
However, the absence of both receptors had a comparable effect
on the production of IL-10 and the phosphorylation of p38, ERK1/
2, and CREB. The potential mechanism that links IL-10 produc-
tion to TLR ligation in BMMs exposed to cercarial E/S products
(hypothesis summarized in Fig. 10) depends on two linked MAPK
cascades. On one hand, p38 was phosphorylated, an event often
reported downstream of TLRs (61, 62), whereas on the other hand,
NF-kB p105 was simultaneously phosphorylated, releasing TPL2,
leading to the activation of ERK1/2 through the phosphorylation
of MEK1/2 (53). Notably, these two kinase cascades occur with
identical activation profiles, leading to the phosphorylation of
CREB reported to be downstream of p38 (14, 16, 63) and ERK1/2
(14, 15, 18). Significantly, a previous study using filarial Ag also
linked CREB activation to the production of IL-10 (64). However,
the full detail of these signaling pathways has not previously been
reported in the context of helminth E/S molecules, and so for the
first time, to our knowledge, we provide a complete molecular
mechanism of IL-10 production by macrophages in response to
schistosome E/S Ags.
The activation of the MAPK pathway described above links with
the early detection of IL-10 mRNA in response to the 0–3hRP and
matches the dynamics of 0–3hRP uptake by BMMs. In this study,
we further demonstrate that the uptake of 0–3hRP is in part me-
diated by PI3K signaling. PI3K signaling is responsible for traf-
ficking of proteins through different cellular compartments (65)—
for example, the PI3K isoform p110-d directs internalization of
TLR4, which thereby limits this receptor’s ability to signal from
the cell surface (66). PI3K signaling is also required for adequate
recruitment of TIRAP to TLRs (67). Consequently, after PI3K
inhibition in 0–3hRP–stimulated BMMs, the reductions in phos-
phorylation of ERK1/2, p38, and CREB, plus diminished IL-10
production, could be due to a combination of reduced 0–3hRP
uptake, blocking TLR receptor trafficking, but also blocking
adequate TIRAP–MyD88 recruitment. As such, PI3K signaling
reveals itself as a crucial initial step in macrophage responses to
cercarial E/S products and potentially to other TLR ligands.
Only a couple of studies provide direct evidence on the inter-
action between CREB and DNA from the IL-10 promoter, and
these are based upon either a highly artificial system (18) or in
conjunction with another transcription factor (16). In this study, it
is demonstrated that in BMMs exposed to cercarial E/S products,
p-CREB is recruited to the IL-10 promoter in a region that
overlaps with the first exon of the gene, which differs from the
findings of the latter study (16). The abundant levels of p-CREB
and its strong interaction with the IL-10 promoter both place this
transcription factor in a privileged place to effectively regulate the
transcription of IL-10. Nevertheless, regulation exerted by CREB
in BMMs exposed to 0–3hRP was not just limited to IL-10. At
least three important transcription factors, Egr1, Fos, and Nfkb2,
were also the target of CREB. Although Egr1 regulates hundreds
of other genes (68), including several cytokines (e.g., TNF-a, IL-
2, and IL-12) (69), its role is not well defined in macrophages. In
contrast, Fos, which is a component of the transcription factor
AP-1 (70) implicated in various inflammatory settings (71), could be
acting in concert with Nfkb2 to induce the production of proin-
flammatory cytokines. Lastly, as the phosphorylation of NF-kB
p65 was evident after exposure of macrophages to 0–3hRP, p65
FIGURE 8. 0–3hRP stimulation increases oxidative phosphorylation over anaerobic glycolysis in BMMs downstream of MEK1/2. Culture supernatants
from BMMs exposed for 18 h to 50 mg/ml 0–3hRP or left unstimulated (media) were tested for the amount of remaining glucose (A) and lactate production
(B). (C and D) BMMs were treated for 2 h with MEK1/2 inhibitor U0126 (10 mmol) and then exposed for 18 h to 50 mg/ml 0–3hRP or left unstimulated
(media). Culture supernatants were tested for the amount of remaining glucose (C) and lactate production (D). Additionally, stimulated BMMs were lysed
and hexokinase activity measured (E). Bars represent the mean difference + SEM of the amount of each metabolite (n = 3) (A–D) or mean fold changes +
SEM (E) in hexokinase activity (n = 3). In all cases, media was used as a reference point arbitrarily set to 0. (A and B) Unpaired two-tailed t tests were
performed to examine differences between means of 0–3hRP–treated cells compared with media. (C and D) ANOVA and Sidak multiple comparisons test
were performed to examine statistically significant differences between control BMMs stimulated with 0–3hRP (black bars) compared with BMMs treated
with MEK1/2 inhibitor then stimulated with 0–3hRP (hatched bars). *p , 0.05, **p , 0.01, ***p , 0.001, ****p , 0.0001. ns, p . 0.05.














could form a complex with p50 released as a consequence of p105
degradation and so form the p50/p65 heterodimer, a well-known
transcription factor for cytokines such as IL-1b, IL-6, and, im-
portantly, IL-12 (13, 72).
In addition to the link between 0–3hRP and IL-10 through TLR
signaling, a large number of genes involved in “metabolic pro-
cess” appear to be regulated by CREB, which targeted genes
associated with components of glycolysis, the tricarboxylic acid
cycle, and oxidative phosphorylation. Moreover, glucose uptake
and hexokinase activity, but not lactate production, were increased
in BMMs stimulated with 0–3hRP, implying that processing and
responding to 0–3hRP is costly from an energy point of view and
FIGURE 9. IL-10 is produced in the skin by two different monocyte populations following S. mansoni cercariae infection. Representative flow cytometry
dot plots (A and C) and mean percentage6 SEM (B, D, and E) of DEC according to expression of MHC-II and F4/80. Gates show R1 (F4/802MHC-IIhigh),
R2 (F4/80+MHC-IIhigh), and R3 (F4/80+MHC-IImid) monocytes. MHC-II+ DEC (A and B) and IL-10/GFP+ MHC-II+ DEC (C–E), recovered from naive
animals or specified days postinfection of WT or IL-10+/GFP mice. (E) IL-10/GFP+ MHC-II+ DEC separated according to expression of F4/80 as in (A).
Symbols are values for cells obtained from individual naive/infected mice. Horizontal bars are the means 6 SEM. n = 4–10 pinnae. ANOVA and Tukey
multiple comparisons test show statistically significant differences between the means of indicated groups. *p , 0.05, ***p , 0.001, ****p , 0.0001. ns,
p . 0.05.














relays on oxidative phosphorylation and not anaerobic gly-
colysis. The interplay and intimate linkage between metabo-
lism and the immune response is becoming increasingly
apparent (73–78), with a particular role for TLR signaling in
modulating metabolism (78, 79). Consequently, our findings
add a mechanistic insight into the manner in which TLR
ligands might impact the metabolism of macrophages. There-
fore, transcription factors such as CREB, involved in cytokine
expression, could also regulate key metabolic process in acti-
vated cells.
Finally, it is important to consider the in vitro observations re-
ported above in the context of in vivo conditions following percu-
taneous infection of a mammalian host, although directly relating
the two can be challenging (42). All S. mansoni life stages in the
mammalian host produce immunomodulatory E/S products (80),
and in this study, we show that E/S products released by invading
S. mansoni larvae have a profound impact upon host macrophages.
The role of tissue-resident macrophages versus blood-derived mono-
cytes in infectious disease immune processes is contentious (81–84),
yet in the skin, we show that tissue-resident F4/80+MHC-IIhigh mac-
rophages, and not recruited monocytes, are the main source of IL-10
early in response to S. mansoni infection. IL-10 production by skin
F4/80+MHC-IIhigh macrophages could be the result of several diverse
signals (stimulation by pathogen-associated molecular patterns, release
of host-derived danger signals resulting from tissue damage following
parasite penetration of the skin, or wound-healing responses); however,
our findings greatly support the role of cercarial E/S products in the
induction of IL-10 production by tissue resident macrophages.
In summary, we present a detailed study of the molecular events
that occur in BMMs following exposure to cercarial E/S products
leading to the production of IL-10. This mechanism involves the
activation of CREB downstream of TLR2 and TLR4 via the
phosphorylation of p38 and ERK1/2. Additionally, we show that
this mechanism is also responsible for the regulation of the met-
abolic state of macrophages, which provides an early in vitro
demonstration of the role helminth Ags have in modulating me-
tabolism downstream of TLRs. Finally, we show that the pro-
duction of IL-10 by macrophages in response to S. mansoni
cercarial E/S products extends beyond an in vitro phenomenon
and is also evident in the skin tissue-resident macrophages, which
rapidly produce IL-10 in vivo following exposure to invading
schistosome larvae. This early and rapid release of IL-10 has the
potential to greatly modulate the immune response in the skin by
limiting inflammation and tissue damage, plus conditioning the
microenvironment recruited immune cells will encounter as they
infiltrate the infection site.
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